SLC5A2 and type 2 diabetes mellitus: This indicates the potential therapeutic benefits of silymarin, a flavonoid with known antioxidant and hepatoprotective properties, as well as dapagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor primarily used in the management of type 2 diabetes, in mitigating the toxic effects of cisplatin.